LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Fedratinib | 0.12 | uM | LJP5 | 2 | L05 | 72 | hr | 765 | 3182 | 3151 | 1.0096 | 1.0094 |
Hs 578T | Fedratinib | 0.12 | uM | LJP5 | 3 | L05 | 72 | hr | 765 | 3144 | 3152 | 0.9973 | 0.9974 |
Hs 578T | Fedratinib | 0.37 | uM | LJP5 | 1 | L04 | 72 | hr | 765 | 2845 | 3140 | 0.9060 | 0.9054 |
Hs 578T | Fedratinib | 0.37 | uM | LJP5 | 2 | L04 | 72 | hr | 765 | 2929 | 3151 | 0.9294 | 0.9295 |
Hs 578T | Fedratinib | 0.37 | uM | LJP5 | 3 | L04 | 72 | hr | 765 | 2785 | 3152 | 0.8835 | 0.8823 |
Hs 578T | Fedratinib | 1.11 | uM | LJP5 | 1 | L03 | 72 | hr | 765 | 2159 | 3140 | 0.6875 | 0.6640 |
Hs 578T | Fedratinib | 1.11 | uM | LJP5 | 2 | L03 | 72 | hr | 765 | 2191 | 3151 | 0.6952 | 0.6739 |
Hs 578T | Fedratinib | 1.11 | uM | LJP5 | 3 | L03 | 72 | hr | 765 | 2120 | 3152 | 0.6725 | 0.6470 |
Hs 578T | Fedratinib | 3.33 | uM | LJP5 | 1 | L02 | 72 | hr | 765 | 977 | 3140 | 0.3111 | 0.1275 |
Hs 578T | Fedratinib | 3.33 | uM | LJP5 | 2 | L02 | 72 | hr | 765 | 1012 | 3151 | 0.3211 | 0.1468 |
Hs 578T | Fedratinib | 3.33 | uM | LJP5 | 3 | L02 | 72 | hr | 765 | 1014 | 3152 | 0.3217 | 0.1479 |
Hs 578T | Fedratinib | 10 | uM | LJP5 | 1 | L01 | 72 | hr | 765 | 362 | 3140 | 0.1153 | -0.3074 |
Hs 578T | Fedratinib | 10 | uM | LJP5 | 2 | L01 | 72 | hr | 765 | 340 | 3151 | 0.1079 | -0.3277 |
Hs 578T | Fedratinib | 10 | uM | LJP5 | 3 | L01 | 72 | hr | 765 | 262 | 3152 | 0.0831 | -0.4082 |
Hs 578T | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 765 | 1179 | 3140 | 0.3754 | 0.2365 |
Hs 578T | Trametinib | 0.04 | uM | LJP5 | 2 | P24 | 72 | hr | 765 | 1218 | 3151 | 0.3865 | 0.2557 |
Hs 578T | Trametinib | 0.04 | uM | LJP5 | 3 | P24 | 72 | hr | 765 | 1180 | 3152 | 0.3743 | 0.2363 |
Hs 578T | Trametinib | 0.12 | uM | LJP5 | 1 | P23 | 72 | hr | 765 | 1030 | 3140 | 0.3280 | 0.1572 |
Hs 578T | Trametinib | 0.12 | uM | LJP5 | 2 | P23 | 72 | hr | 765 | 1092 | 3151 | 0.3465 | 0.1903 |
Hs 578T | Trametinib | 0.12 | uM | LJP5 | 3 | P23 | 72 | hr | 765 | 1031 | 3152 | 0.3271 | 0.1573 |
Hs 578T | Trametinib | 0.37 | uM | LJP5 | 1 | P22 | 72 | hr | 765 | 1035 | 3140 | 0.3296 | 0.1599 |
Hs 578T | Trametinib | 0.37 | uM | LJP5 | 2 | P22 | 72 | hr | 765 | 1004 | 3151 | 0.3186 | 0.1423 |
Hs 578T | Trametinib | 0.37 | uM | LJP5 | 3 | P22 | 72 | hr | 765 | 1076 | 3152 | 0.3413 | 0.1817 |
Hs 578T | Trametinib | 1.11 | uM | LJP5 | 1 | P21 | 72 | hr | 765 | 1018 | 3140 | 0.3242 | 0.1505 |
Hs 578T | Trametinib | 1.11 | uM | LJP5 | 2 | P21 | 72 | hr | 765 | 927 | 3151 | 0.2941 | 0.0986 |